The SoftBank-backed e-commerce services platform developer listed on the New York Stock Exchange, pricing the shares above their range.

BNP Paribas, SBI Group, Siam Commercial Bank, GV and Rakuten are set to exit the cross-border payment platform in a $963m acquisition by Visa.

Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.

Panakès Partners is now targeting a final close upwards of $210m for its Purple Fund, which has reached its Menarini-backed first close.

6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.

Citi Ventures helped the expense management platform developer raise series C funding which will be used to accelerate product development and expansion across Europe.

Telefónica-backed addiction treatment app developer Quit Genius raised $64m while oral care product maker NYSCPS received almost as much in a round featuring ByteDance.

Eric Leupoldis set to oversee cash markets for Germany-based stock exchange Deutsche Boerse having been managing director of DB1 Ventures for 18 months.

The internal promotion at Merck Group's corporate venturing subsidiary followed the departure in May of Jasper Bos.

Debt repayment platform developer InDebted received $18.4m from investors including MassMutual, while corporate-backed AdaptiveMobile, Immersal and Pocket Casts are all being acquired.